Function of NLRP3 inflammasome activation in multiple myeloma

1. LPS+ATP can activate NLRP3 inflammasome in multiple myeloma cells. 2. Activation of NLRP3 inflammasome inhibits the early apoptosis of myeloma cells induced by dexamethasone and bortezomib.

Authors

Institutions

Publication Details

Journal
Hematology
Published
2024-09-13
DOI
https://doi.org/10.1080/16078454.2024.2399367
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Function of NLRP3 inflammasome activation in multiple myeloma

Xueyun Zhao, Lianjuan Wang, Lingkai Chen, Xiaorong Zhu et al.
Hematology
Multiple Myeloma Research and Treatments
article

Function of NLRP3 inflammasome activation in multiple myeloma

Xueyun Zhao, Lianjuan Wang, Lingkai Chen, Xiaorong Zhu, Ning Xu, Yanhong Jia, Mingqiang Hua, Jie Yu
article en

Abstract

1. LPS+ATP can activate NLRP3 inflammasome in multiple myeloma cells. 2. Activation of NLRP3 inflammasome inhibits the early apoptosis of myeloma cells induced by dexamethasone and bortezomib.

HematologyVol. 29(1)
Shandong University (CN), Weihai Municipal Hospital (CN), Baotou Central Hospital (CN)
Inner Mongolia University
Zero hunger
Openalex Percentile: Top 76%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.